510(k) device
LEGION Porous CR Narrow Femoral Components
Smith & Nephew, Inc. · Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer (MBH, Class II) · First FDA decision Dec 20, 2007, newest Mar 25, 2021Knee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
12
Naming "LEGION"
MAUDE reports
0
Brand "LEGION", since 2015
PubMed studies
459
Mentioning "LEGION"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LEGION Porous CR Narrow Femoral Components
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 4 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "LEGION", any status and sponsor, newest update first.
Smith & Nephew, Inc.Public (SNN)
NCT07199738 · 144 participants (planned) · Start Sep 25, 2025 · Primary completion Dec 2036
Device: Cemented CoCr; Cemented Oxinium and 1 more · For: Inflammatory Arthritis; Primary Total Knee Arthroplasty Due to Degenerative Joint Disease (Primary Diagnosis of Osteoarthritis); Post-traumatic Arthritis
Sites: Newton, Massachusetts; New York, New York; Charleston, South Carolina · 4 sites in all
- Safety and Performance Study of the Legion Porous System in Total Knee ArthroplastyActive, not recruiting
Smith & Nephew, Inc.Public (SNN)
NCT03720782 · 118 participants · Start May 22, 2019 · Primary completion Jan 23, 2031
Device: LEGION Porous HA Tibial Baseplate and/or the LEGION Porous HA CR Femoral Component · For: Total Knee Arthroplasty
Sites: Coon Rapids, Minnesota; St Louis, Missouri
- Safety and Performance Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial InsertsActive, not recruiting
Smith & Nephew, Inc.Public (SNN)
NCT03687593 · 126 participants · Start Aug 26, 2018 · Primary completion Oct 1, 2027
Device: Legion™ CR Oxinium and CoCr Femoral Implants combined with Legion™/Genesis™ II XLPE High Flex Tibial Inserts · For: Total Knee Arthroplasty
Sites: Edina, Minnesota; Reno, Nevada; Greenville, South Carolina · 4 sites in all
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LEGION", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MBH
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "LEGION"[tiab]. The summary above synthesizes these.
- Harvey's Story.
Reiner A · J Comp Neurol · 2024Historical Article
- Legion: An Instrument for High-Throughput Electrochemistry.
Gerroll BHR, Kulesa KM, Ault CA, et al. · ACS Meas Sci Au · 2023
- Editorial.
Leach CW · J Pers Soc Psychol · 2021Editorial
- Oropharyngeal dysphagia.
Bulat RS, Orlando RC · Curr Treat Options Gastroenterol · 2005
- Limp.
Hensinger RN · Pediatr Clin North Am · 1986
- Reversible dementias.
Kabasakalian A, Finney GR · Int Rev Neurobiol · 2009Review
- The challenges were legion.
Fraser DW · Lancet Infect Dis · 2005Historical Article
- Ways of preventing surgeon burnout.
Naviaux AF, Barbier L, Chopinet S, et al. · J Visc Surg · 2023
- Nonprimary dystonias.
Dressler D · Handb Clin Neurol · 2011Review
- My Name Is Legion, for We Are Many-The Complex Community of Antibody Receptors.
Biburger M · Int J Mol Sci · 2023Editorial
Other devices of this type
Also filed under product code MBH.
- Zimmer® Persona® Personalized Knee SystemZimmer, Inc. · 510(k) 2026
- Persona the Personalized Knee System (Persona Porous Plasma Spray PPS Femurs)Zimmer, Inc. · 510(k) 2026
- Physica System (Physica CR Porous Femoral components)Lima Corporate S.P.A. · 510(k) 2025
- ATTUNE® Porous Fixed Bearing Tibial BaseDepuy Ireland UC · 510(k) 2024
- Arthrex iBalance TKA SystemArthrex, Inc. · 510(k) 2016
- Genesis II Total Knee SystemSmith & Nephew, Inc. · 510(k) 2007
- GMK 3D Metal Tibial Tray ExtensionMedacta International S.A. · 510(k) 2026
- Triathlon® Total Knee System - Triathlon® X3® Medial Stabilized Tibial Bearing InsertHowmedica Osteonics Corp., Dba Stryker Orthopaedics · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.